The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
A Mechanistic Study of Enhanced Doxorubicin Uptake and Retention in Multidrug Resistant Breast Cancer Cells Using a Polymer-Lipid Hybrid Nanoparticle System
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Mechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643 · cited 3×
“…glycoprotein that may actively extrude several substrates, including a variety of cytotoxic drugs such as doxorubicin (Dox), from cell cytoplasm to outside of plasma membrane, thus lowering the effective drug concentrations within the cells (Endicott and Ling, 1989; Gottesman, 2002).”
BackgroundTHE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE
Endicott, J. A., & Ling, V. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.001033 · Cited by 2,071
Molecular mechanisms of drug resistance
Longley, D., & Johnston, P. (2005) · The Journal of Pathology · doi:10.1002/path.1706 · Cited by 1,672
Pluronic® block copolymers for overcoming drug resistance in cancer
Kabanov, A. V., Batrakova, E. V., & Alakhov, V. Y. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00047-9 · Cited by 636
Evers, R., Kool, M., van Deemter, L., Janssen, H., Calafat, J., Oomen, L. C., Paulusma, C. C., Oude Elferink, R. P., Baas, F., Schinkel, A. H., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119886 · Cited by 620
Miller, C. R., Bondurant, B., McLean, S. D., McGovern, K. A., & O'Brien, D. F. (1998) · Biochemistry · doi:10.1021/bi980096y · Cited by 524
Panyam, J., & Labhasetwar, V. (2003) · Pharmaceutical Research · doi:10.1023/a:1022219003551 · Cited by 466
Poloxamers and poloxamines in nanoparticle engineering and experimental medicine
Moghimi, S. M., & Hunter, A. C. (2000) · Trends in Biotechnology · doi:10.1016/s0167-7799(00)01485-2 · Cited by 392
Wong, H. L., Rauth, A. M., Bendayan, R., Manias, J. L., Ramaswamy, M., Liu, Z., Erhan, S. Z., & Wu, X. Y. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0282-x · Cited by 303
Self-citationBatrakova, E., Lee, S., Li, S., Venne, A., Alakhov, V., & Kabanov, A. (1999) · Pharmaceutical Research · doi:10.1023/a:1018942823676 · Cited by 289
Lee, K.-D., Hong, K., & Papahadjopoulos, D. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90086-2 · Cited by 240
Romsicki, Y., & Sharom, F. J. (1999) · Biochemistry · doi:10.1021/bi990064q · Cited by 235
Ramge, P., Unger, R. E., Oltrogge, J. B., Zenker, D., Begley, D., Kreuter, J., & Von Briesen, H. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00078.x · Cited by 197
Lamprecht, A., Yamamoto, H., Takeuchi, H., & Kawashima, Y. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.088146 · Cited by 187
Wong, H. L., Bendayan, R., Rauth, A. M., & Wu, X. Y. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20100 · Cited by 178
Self-citationde Verdière, A., Dubernet, C., Némati, F., Soma, E., Appel, M., Ferté, J., Bernard, S., Puisieux, F., & Couvreur, P. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.362 · Cited by 168
Handbook of cancer chemotherapy
(1993) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(93)90321-b · Cited by 158
Handbook of Clinical Drug Data.
Montejo, M., Lizárraga, M. A., Merino, J., de la Hoz, C., Barron, J., Merino, A. C., Layuno, F., & Aguirre, C. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-89-4-582_3 · Cited by 122
Modulation of doxorubicin resistance in multidrug‐resistant cells by liposomes
Thierry, A. R., Vigé, D., Coughlin, S. S., Belli, J. A., Dritschilo, A., & Rahman, A. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.6.8097173 · Cited by 105
Cellular localization and functional expression of P‐glycoprotein in rat astrocyte cultures
Ronaldson, P. T., Bendayan, M., Gingras, D., Piquette‐Miller, M., & Bendayan, R. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02417.x · Cited by 89
Self-citationCationic Liposome-Mediated Gene Delivery In vivo
Templeton, N. S. (2002) · Bioscience Reports · doi:10.1023/a:1020142823595 · Cited by 81
Soma, C. E., Dubernet, C., BARRATT, G. M., Némati, F., Appel, M., Benita, S., & Couvreur, P. (1999) · Pharmaceutical Research · doi:10.1023/a:1018902031370 · Cited by 78
Phase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancer
Booser, D. J., Esteva, F. J., Rivera, E., Valero, V., Esparza-Guerra, L., Priebe, W., & Hortobágyi, G. N. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-002-0464-0 · Cited by 67
Characterization of Nanostructure of Stimuli-Responsive Polymeric Composite Membranes
Zhang, K., Huang, H., Yang, G., Shaw, J. E., Yip, C. M., & Wu, X. Y. (2004) · Biomacromolecules · doi:10.1021/bm034458f · Cited by 47
Self-citationInteraction of Cationic Colloids at the Surface of J774 Cells: A Kinetic Analysis
Chenevier, P., Veyret, B., Roux, D., & Henry, N. (2000) · Biophysical Journal · doi:10.1016/s0006-3495(00)76383-1 · Cited by 39
Veldman, R. J., Koning, G. A., van Hell, A. J., Zerp, S. F., Vink, S. R., Storm, G., Verheij, M., & BLITTERSWIJK, W. J. V. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.087486 · Cited by 37
Lam, K. H., Leung, C., Chan, H., & Fong, W. F. (2000) · Anti-Cancer Drugs · doi:10.1097/00001813-200006000-00008 · Cited by 33
CHEUNG, R., Rauth, A. M., Ronaldson, P. T., Bendayan, R., & Wu, X. Y. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.09.011 · Cited by 32
Self-citationAu, J. L. ‐., Millenbaugh, N. J., & Wientjes, M. G. (2000) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050039 · Cited by 26
Cited by
Therapeutic Nanoparticles for Drug Delivery in Cancer
Cho, K., Wang, X., Nie, S., Chen, Z. (., & Shin, D. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1441 · Cited by 2,920
Cellular uptake of nanoparticles: Journey inside the cell
Behzadi, S., Serpooshan, V., Tao, W., Hamaly, M. A., Alkawareek, M. Y., Dreaden, E. C., Brown, D., Alkilany, A. M., Farokhzad, O. C., & Mahmoudi, M. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00636a · Cited by 2,859
Endocytic mechanisms for targeted drug delivery☆
BAREFORD, L., & SWAAN, P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.008 · Cited by 1,033
Recent progress in tumor pH targeting nanotechnology
Lee, E. S., Gao, Z., & Bae, Y. H. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.003 · Cited by 866
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come
Yingchoncharoen, P., Kalinowski, D. S., & Richardson, D. R. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.012070 · Cited by 744
Metadata
- Authors
- Wong, H. L., Bendayan, R., Rauth, A. M., Xue, H. Y., Babakhanian, K., & Wu, X. Y.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2006-06
- Volume
- 317
- Issue
- 3
- Pages
- 1372-1381
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2133591717
- Cited by
- 344
- References
- 30
- FWCI
- 7.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.